Cargando…

Clinicopathologic characteristics and prognosis of Borrmann type IV gastric cancer: a meta-analysis

BACKGROUND: The clinicopathologic features and surgical treatment strategy of Borrmann type IV (B-4) gastric cancer remains controversial. This meta-analysis was conducted to evaluate the clinicopathologic features of patients with B-4 gastric cancer and to assess whether or not non-curative resecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Yifan, Gao, Peng, Song, Yongxi, Sun, Jingxu, Huang, Xuanzhang, Zhao, Junhua, Ma, Bin, Li, Yuan, Wang, Zhenning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765022/ https://www.ncbi.nlm.nih.gov/pubmed/26912240 http://dx.doi.org/10.1186/s12957-016-0805-9

Ejemplares similares

Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis
por: Sun, Jingxu, et al.
Publicado: (2016)

Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis
por: Chen, Xiaowan, et al.
Publicado: (2016)

Clinicopathological and prognostic features of Borrmann type IV gastric cancer versus other Borrmann types: A unique role of signet ring cell carcinoma
por: Liang, Chengcai, et al.
Publicado: (2023)

Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer
por: Huang, Xuanzhang, et al.
Publicado: (2015)

Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis
por: Huang, Xuanzhang, et al.
Publicado: (2014)

Conversion Surgery for Stage IV Gastric Cancer
por: Zhang, Fei, et al.
Publicado: (2019)

Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis
por: Wu, Zhonghua, et al.
Publicado: (2017)

Clinicopathological features and Borrmann classification associated with HER2-positive in primary gastric cancer
por: Dai, Xiaomin, et al.
Publicado: (2019)

Are Borrmann’s Types of Advanced Gastric Cancer Distinct Clinicopathological and Molecular Entities? A Western Study
por: Díaz del Arco, Cristina, et al.
Publicado: (2021)

Subtotal gastrectomy combined with chemotherapy: An effective therapy for patients with circumscribed Borrmann type IV gastric cancer
por: Huang, Hai-Bo, et al.
Publicado: (2020)

Muscle RAS oncogene homolog (MRAS) recurrent mutation in Borrmann type IV gastric cancer
por: Yasumoto, Makiko, et al.
Publicado: (2016)

Prognostic impact and implications of extracapsular lymph node spread in Borrmann type IV gastric cancer
por: Dong, Rui-Zeng, et al.
Publicado: (2017)

A panel consisting of three novel circulating lncRNAs, is it a predictive tool for gastric cancer?
por: Liu, Jingjing, et al.
Publicado: (2018)

Correlation between sialyl Tn antigen and lymphatic metastasis in patients with Borrmann type IV gastric carcinoma.
por: Kakeji, Y., et al.
Publicado: (1995)

A difficult‐to‐diagnose case of Borrmann type IV gastric cancer with marked transverse colon stenosis
por: Natsui, Kazuki, et al.
Publicado: (2022)

A Transfer Learning Radiomics Nomogram for Preoperative Prediction of Borrmann Type IV Gastric Cancer From Primary Gastric Lymphoma
por: Feng, Bao, et al.
Publicado: (2022)

Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials
por: Sun, Jingxu, et al.
Publicado: (2012)

Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis
por: Sun, Jingxu, et al.
Publicado: (2013)

Prognostic value of gastric cancer‐associated gene signatures: Evidence based on a meta‐analysis using integrated bioinformatics methods
por: Wang, Jun, et al.
Publicado: (2018)

MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer
por: Shi, Jinxin, et al.
Publicado: (2021)

Impact of AADAC gene expression on prognosis in patients with Borrmann type III advanced gastric cancer
por: Wang, Yufei, et al.
Publicado: (2022)

Retrospective evaluation of lymphatic and blood vessel invasion and Borrmann types in advanced proximal gastric cancer
por: Gao, Shan, et al.
Publicado: (2019)

Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis
por: Yang, Yuchong, et al.
Publicado: (2016)

PN3b as an independent risk factor for poor prognosis and peritoneal recurrence in Borrmann type IV gastric cancer: A retrospective cohort study
por: Chen, Yiran, et al.
Publicado: (2022)

The potential adjunctive benefit of adding metformin to standard treatment in inoperable cancer patients: a meta-analysis of randomized controlled trials
por: Wu, Zhonghua, et al.
Publicado: (2020)

Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer
por: Ma, Bin, et al.
Publicado: (2016)

Long noncoding RNAs in gastric cancer: functions and clinical applications
por: Wang, Jiajun, et al.
Publicado: (2016)

Type-Specific Diagnosis and Evaluation of Longitudinal Tumor Extent of Borrmann Type IV Gastric Cancer: CT versus Gastroscopy
por: Kim, Jung Im, et al.
Publicado: (2013)

The Efficacy and Toxicity of Paclitaxel Plus S-1 Compared With Paclitaxel Plus 5-Fu for Advanced Gastric Cancer: A PRISMA Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Liu, Huan, et al.
Publicado: (2014)

Do Patients with Second Primary Colorectal Cancer Hold the Similar Prognosis and Therapeutic Benefits as Those with Initial Primary Colorectal Cancer?
por: Chen, Quan, et al.
Publicado: (2018)

Borrmann Type 4 Advanced Gastric Cancer: Focus on the Development of Scirrhous Gastric Cancer
por: Jung, Kyoungwon, et al.
Publicado: (2016)

A nomogram for predicting bowel obstruction in preoperative colorectal cancer patients with clinical characteristics
por: Lv, Xinger, et al.
Publicado: (2019)

Proliferative activity as a prognostic factor in Borrmann type 4 gastric carcinoma.
por: Kakeji, Y., et al.
Publicado: (1994)

An Insufficient Preoperative Diagnosis of Borrmann Type 4 Gastric Cancer in Spite of EMR
por: Ahn, Jae Bong, et al.
Publicado: (2011)

Prognostic significance of Borrmann type combined with vessel invasion status in advanced gastric cancer
por: Zhai, Zhao, et al.
Publicado: (2020)

The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta‐analysis
por: Zhong, Xi, et al.
Publicado: (2018)

Quantitative global proteome and lysine succinylome analyses provide insights into metabolic regulation and lymph node metastasis in gastric cancer
por: Song, Yongxi, et al.
Publicado: (2017)

Gastric Carcinoma in Young Patients and Its Clinicopathological Characteristics and Prognosis
por: Sandeep, Bhushan, et al.
Publicado: (2020)

Predicting the effect of 5‐fluorouracil–based adjuvant chemotherapy on colorectal cancer recurrence: A model using gene expression profiles
por: Chen, Quan, et al.
Publicado: (2020)

The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer
por: Fu, Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kghflsour4j1jsgga977h1d2mh